Available clinical data does not as yet support any conclusion about the development of therapy resistance in children on continuous treatment for ALK-fusion positive tumors, although case reports exist in the inflammatory myofibroblastic tumor (IMT) literature (Mosse et al., 2013). This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.